Physician

Brian Kelley

According to 2025 Medicare claims, Brian Kelley (NPI: 1194213785) practices interventional cardiology in the Wilmington, NC market, with the plurality of this provider's patient population coming from Brunswick, NC. This provider's primary affiliated billing organization is NOVANT HEALTH MEDICAL GROUP COASTAL REGION, LLC (NPI: 1649865791; TIN: 581728803) and primary practice location at 28401-7407.

Kelley's data goes back to 2015 and runs through 2024. Part D data shows 339 prescription claims across 69 beneficiaries totaling $57,190 in drug costs, led by Jardiance (Empagliflozin). Open Payments data shows 5 records totaling $810. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have risen steadily, from $11,202 to $57,190. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

No connected Part B records

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	46	158	$11,202
2019	76	408	$21,672
2020	68	453	$51,396
2021	64	527	$41,875
2022	72	438	$66,359
2023	70	355	$46,324
2024	69	339	$57,190

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

No connected Part B code-level records for 2024.

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jardiance	Empagliflozin	13	810	$16,306
Eliquis	Apixaban	18	600	$12,304
Repatha Sureclick	Evolocumab	15	588	$11,112
Clopidogrel	Clopidogrel Bisulfate	25	1,560	$473
Atorvastatin Calcium	Atorvastatin Calcium	31	2,250	$436

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	5	$810	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Brian Kelley?

Tedicare shows public-source Medicare data for Brian Kelley (NPI 1194213785), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Brian Kelley have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Brian Kelley?

Brian Kelley is linked to NOVANT HEALTH MEDICAL GROUP COASTAL REGION, LLC (billing NPI 1649865791) in the available physician profile data.

Does Brian Kelley have Open Payments data?

Brian Kelley has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.